Therapeutics: Peroxisome proliferation activated receptor γ (PPARγ); phosphatase and tensin homolog deleted on chromosome ten (PTEN; MMAC1; TEP1)

Cancer

INDICATION: Prostate cancer

Patient sample, cell culture and mouse studies suggest inhibiting PPARγ could help treat PTEN-deficient prostate cancer. In

Read the full 196 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE